RJMPDRN REC is a vegan-certified recombinant PDRN produced through a patented biological synthesis platform using engineered ...
Preclinical evaluation in mice assessed the potential of the Nanobiotix Nanoprimer to overcome common barriers faced by lipid nanoparticle(“LNP”)-delivered therapies related to rapid liver ...
Key opportunities in the bevacizumab biosimilars market arise from increasing cancer prevalence, demand for cost-effective ...
Explore the contrasting acceptance of gene therapy and genetic crop modification, highlighting societal attitudes and ...
Canada's Pinnacle Food Group has signed an MoU to explore the establishment of an Open Yeast Platform hub for precision ...
Nanobiotix ( (NBTX)) has issued an update. On April 20, 2026, Nanobiotix reported new preclinical data for its Nanoprimer platform, presented at the American Association for Cancer Research annual ...
KATY, TX / ACCESS Newswire / April 30, 2026 / A groundbreaking study published in the prestigious journal Cell Metabolism ...
Canada's AuX Labs has raised $4M in funding to scale up production of its precision-fermented dairy protein and bring ...
WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today ...
Brii Biosciences Limited ("Brii Bio," "Brii," or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet ...
Objectives Over the last decade, a growing number of health interventions (eg, medical assistance in dying and mitochondrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results